Lamer

  1. Asian Stocks Rise After US Inflation Backs Fed Cut: Markets Wrap

    Asian stocks rose Thursday after US equities snapped a two-day slide on benign inflation data that supported
    expectations of a Federal Reserve interest-rate cut this month. Japanese and Hong Kong stocks led gains in
    the region, with the MSCI Asia Pacific index on pace for the highest close in over a month. The rally was
    driven by technology names after the Nasdaq 100 surged to a record high on Wednesday. US stock futures
    edged lower.

  2. Nasdaq surges for first close above 20,000, lifted by Alphabet shares

    The Nasdaq Composite surged Wednesday after November’s inflation report met economists’ projections,
    clearing the way for the Federal Reserve to cut interest rates again at its December meeting next week.
    The tech-heavy index rose 1.77% to end at 20,034.89 and post an all-time high and a closing record. The
    broad market S&P 500 gained 0.82% to close at 6,084.19. The Dow Jones Industrial Average was the outlier,
    falling 99.27 points, or 0.22%, to 44,148.56.

  3. Oil little changed as demand weakness offsets sanctions-driven supply risks

    Oil prices were little changed in early Asian trade on Thursday as forecasts of weak demand and a higher
    than-expected rise in U.S. gasoline and distillate inventories stemmed gains from an additional round of
    European Union sanctions that threatened Russian oil flows. Brent crude futures were down 5 cents at
    $73.47 a barrel at 0141 GMT. U.S. West Texas Intermediate crude futures fell 11 cents to $70.18. Both
    benchmarks rose over $1 each on Wednesday. OPEC cut its demand growth forecasts for 2025 for the fifth
    straight month on Wednesday and by the largest amount yet.

  4. Gold advances as inflation data fuels Fed rate cut optimism

    Gold gained on Wednesday after an inflation print came in line with expectations, boosting the likelihood of a
    Federal Reserve rate cut next week, while investors awaited U.S. Producer Price Index (PPI) data for further
    direction on monetary policy. Spot gold climbed 1% to $2,719.40 per ounce. U.S. gold futures rose 1.4% to
    $2,756.4. The U.S. consumer prices rose 0.3% on a monthly basis in November, data from the Labor
    Department showed. Annually, it climbed 2.7% after increasing 2.6% in October. Economists polled by
    Reuters had forecast the CPI rising 0.3% and advancing 2.7% year-on-year.

  5. US Inflation in Line With Forecasts Solidifies Bets on Fed Cut

    US consumer prices rose at a firm pace in November that was in line with expectations, solidifying
    expectations for the Federal Reserve to cut interest rates next week. The so-called core consumer price
    index, which excludes food and energy costs, increased 0.3% for a fourth straight month, Bureau of Labor
    Statistics figures showed Wednesday. From a year ago, it rose 3.3%.

  6. BOJ Is Said to See Little Cost to Waiting for Next Rate Hike

    Bank of Japan officials see little cost to waiting before raising interest rates while still being open to a hike
    next week depending on data and market developments, according to people familiar with the matter. Even
    if the BOJ decides to wait until January or a while longer, authorities see it as not entailing a huge cost
    because signs point to limited risk that inflation might overshoot, the people said. At the same time, some
    officials are not against a rate hike at this meeting if it is proposed, according to the people. The yen
    weakened against the dollar following the report, after some whipsawing. It briefly hit 152.82 against the
    greenback around 10:25 p.m. in Tokyo, after earlier trading at around 151.60. It was moving at around
    152.10 to the dollar Thursday morning.

  7. China’s monetary shift signals economic worries, but bazooka-style stimulus is unlikely, experts say

    Chinese government in 2008 had unleashed a historically large monetary stimulus in response to the global
    financial crisis, Gabriel Wildau, managing director of Teneo said. Potential monetary easing leeway is much
    more limited than 15 years ago, said Tao Wang, head of Asia economics and chief China economist at UBS
    Investment Bank. The People’s Bank of China cut its benchmark 1-year lending rate by a total of 156 basis
    points and the cash reserves ratio by 1.5 percentage points during the 2008 easing cycle.

  8. European Central Bank heads for last rate cut of year, but jumbo move seems off the table

    The European Central Bank is widely expected to deliver a 25-basis-point rate cut on Thursday, rather than a
    jumbo 50-basis-point move previously thought to be on the table. Economists nevertheless say downside
    risks to the euro zone economy and the inflation picture have both increased, set to send the central bank on
    a faster course of monetary loosening in 2025. Macro forecasts broadly are citing high uncertainty around
    the policies of U.S. President-elect Donald Trump.

  9. India’s ReNew Energy offered to be taken private in $2.82 billion deal

    Some of the biggest investors in ReNew Energy Global have offered to take the company private, filings to
    the U.S. Securities And Exchange Commission show, in a deal that values the clean power generator at $2.82
    billion, according to Reuters calculations. Major shareholders Canada Pension Plan Investment Board, UAE
    based Masdar, ReNew Chairman Sumant Sinha and a unit of the Abu Dhabi Investment Authority have
    offered to buy shares in India’s second largest clean energy generator at $7.07 each. The consortium has
    collective voting rights of 64% in ReNew, which is India’s second biggest renewable energy firm after Adani
    Green.The offer represents an 11.5% premium to ReNew’s closing price of $6.34 on Nasdaq on Dec. 10. The
    valuation is based on a total of 398.61 million diluted shares outstanding as of Aug. 15, according to the
    company’s website. Shares of ReNew closed 17.7% higher at $7.46 on the Nasdaq on Wednesday, 5.5%
    above the offer price. ReNew operates 10.3 gigawatts of solar, wind, hydro and hybrid projects across India.
    Its stock had lost nearly 18% of its value this year before the offer was made.

  10. Budget deficit swells in November, pushing fiscal 2025 shortfall 64% higher than a year ago

    The U.S. budget deficit swelled in November, putting fiscal 2025 already at a much faster pace than a year
    ago when the shortfall topped $1.8 trillion, the Treasury Department reported Wednesday. For the month,
    the deficit totaled $366.8 billion, 17% higher than November 2023 and taking the total for the first two
    months of the fiscal year more than 64% higher than the same period a year ago on an unadjusted basis. The
    increase came despite receipts that totaled $301.8 billion, about $27 billion more than last November.
    Outlays totaled $668.5 billion, or nearly $80 billion more from a year ago. The increase in red ink brought the
    national debt to $36.1 trillion as the month drew to a close. On an adjusted basis, the deficit was $286 billion
    and has totaled $544 billion year to date, an increase of 19%.

  11. Auto giants endured a torrid time of it this year and few expect 2025 to be much better

    Automakers have struggled to come to terms with a series of headwinds, including a lack of affordable
    models, a slower-than-anticipated rollout of charging points, intense competition from China, tougher carbon
    regulations and the prospect of targeted U.S. tariffs. It is against this backdrop, analysts say, that the industry
    will be bracing for a bumpy ride next year. Unfortunately, we believe the industry is likely to head into
    another year of volatility and headwinds across regions, analysts at Deutsche Bank said in a research note.

  12. Alphabet shares rose 5.5% Wednesday, building on Tuesday’s gain of 5.6%

    The rally is coming amid excitement over a major development in quantum computing through the use of
    Google’s Willow quantum chip. BofA affirmed a buy rating and $210 price target on the stock, writing that
    advancements with Willow, which illustrate that Alphabet remains at the leading edge of technology
    innovation, are important for stock sentiment. Over the long term, quantum innovation has the potential to
    create a significant tech moat for Alphabet, and in the near term, we think that Google‘s innovation with
    [Tensor Processing Units] could be underappreciated, as TPU advancements could accelerate the training and
    inference of Google‘s own AI models while improving cost efficiency versus peers. Scotiabank also sees this as
    significant, as without quantum computing many future applications of AI won’t be feasible. Investors and
    companies alike tend to underestimate the industry-changing impacts that quantum computing can have,
    especially regarding data privacy and security, as well as crypto. Sector outperform rating, PT $212.

  13. Tesla shares rose 5.9% on Wednesday amid a rally on expectations that the company’s self-driving
    business will get a boost under a Trump presidency

    After largely languishing behind its mega-cap technology peers for most of 2024, Tesla shares have climbed
    sharply since late October, lifted first by better-than-expected third-quarter results and then the expectation
    that Donald Trump’s election win could be positive for the company. Tesla’s CEO Elon Musk was an avid
    supporter of Trump during the US presidential election and is leading an effort to slash at least $2 trillion
    from the federal budget.

  14. Shares of US health-care companies that own pharmacy benefit management units fell on Wednesday
    after lawmakers drafted legislation that would force prescription drug middlemen to divest pharmacies
    they own. Leerink Partners says that while the bill is unlikely to pass, it would be the farthest-reaching
    attempt to intervene on PBMs’ operating model


    UnitedHealth fell 5.6% while Cigna and CVS Health fell 5.6% and 6.1% respectively. Evercore ISI, Elizabeth
    Anderson: Says the report comes as the most recent in a long series of government initiatives to further
    regulate PBMs given rising cost burdens to patients and the fact that purchasing prescription drugs is one of
    voters’ most frequent interactions with their healthcare coverage. Sees report as incremental in its bi
    partisan nature but with a low probability of passing as Congress is in the process of wrapping up its current
    session. Notes headline risk for now, but a higher chance in 2025 that is still less than 50% likely. Leerink
    Partners, Michael Cherny: Says the potential legislation is unlikely to gain traction, although it is hard to
    dismiss outright. Says even with more support and attention, a breakup of PBMs would likely be quite
    challenging to execute. We do not think the new proposed legislation materially increases the risk of
    meaningful FTC/Congressional action at this point, although SOME regulation passing at some point would
    not be shocking.

  15. Adobe Inc. fell 9.3% in afterhours trading after giving a disappointing annual sales outlook,
    underscoring anxieties that the creative software company may lose business to emerging artificial
    intelligence-based startups


    Revenue will be about $23.4 billion in the fiscal year ending in November 2025, the company said. Earnings,
    excluding some items, will be $20.20 a share to $20.50 a share. Analysts, on average, estimated sales of $23.8
    billion and adjusted profit of $20.52 a share. Adobe, known for its software for creative professionals, has
    been adding generative AI features to its applications, such as embedding its proprietary model, Firefly, into
    products like Photoshop. The company unveiled an AI tool to create videos during its annual user conference
    in October, which has been integrated into editing app Premiere and is slowly rolling out to the wider public.
    The software maker will soon introduce a new higher-priced Firefly offering, which includes video models,
    David Wadhwani, who leads the company’s creative business, said. A closely watched metric of new creative
    software business, digital media net new annual recurring revenue, will increase 11% in the fiscal year, in line
    with estimates. Factored into guidance is an ongoing strategy to introduce new tiered subscription offerings
    and add-ons, Chief Financial Officer Dan Durn said. Adobe’s outlook may be conservative due to the
    uncertain pace at which AI usage may take root, wrote Anurag Rana, an analyst at Bloomberg Intelligence.
    Investors have voiced recurring anxieties that AI-based creative tools from firms like OpenAI or Runway AI
    could take market share from Adobe.

  16. SpaceX valuation surges to $350 billion as company buys back stock

    The valuation of Elon Musk’s SpaceX hit $350 billion based on a secondary share sale, CNBC confirmed on
    Wednesday. SpaceX and investors agreed to buy stock from insiders in a $1.25 billion purchase offer at $185
    a share, according to copies of the offer obtained by CNBC. SpaceX’s soaring valuation, ranking well above
    U.S. defense contractors and among the top 25 in the S&P 500 by market cap, comes as the company
    furthers its dominant position in the space industry.

  17. Healthcare stocks fall as lawmakers push for bill to break up drug middlemen

    Shares of companies owning pharmacy benefit managers fell on Wednesday after the introduction of a
    bipartisan bill that would force health insurers or drug middlemen to divest their pharmacy businesses.
    CVS Health (NYSE:CVS)’s Caremark, Cigna (NYSE:CI)’s Express Scripts and UnitedHealth Group (NYSE:UNH)’s
    Optum control the majority of pharmacy benefit management (PBMs) in the US, while their parent
    companies also operate health insurance businesses. Shares of all three companies were down between 4.8%
    to 5.5% after the Wall Street Journal first reported news of the bill. The bill, sponsored by U.S. Senators
    Elizabeth Warren, a Democrat, and Josh Hawley, a Republican, will force companies owning health insurers
    or pharmacy benefit managers to divest their businesses operating pharmacies within three years.

Leave a Reply

Your email address will not be published. Required fields are marked *